Loading...
Images of Younes Hazza A.
(0 from 0 )News
Google News: Hematology & Stem Cell Transplantation Program
[Clinical Oncology News] - Younes A, Kim S, Romaguera J, et al. Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma. J Clin Oncol
sorted by relevance / date